Pirfenidone Capsule 267 mg Suppliers & Bulk Manufacturers
Available Forms: Capsules
Available Strengths: 267 mg
Reference Brands: Esbriet (USA/EU)
Category: Respiratory Disorder
Pirfenidone 267 mg hard capsules, an oral antifibrotic for idiopathic pulmonary fibrosis. Listed for importers, distributors and hospital pharmacies sourcing specialist respiratory medicines.
Manufacture or export Pirfenidone Capsule? List it or send an offer →
Product Description:
Pirfenidone is an oral antifibrotic medicine. Its exact mechanism is not fully known, but it reduces fibroblast growth and the production of collagen and of growth factors such as TGF-beta that drive scarring, and it has anti-inflammatory effects. This page lists 267 mg hard capsules. The capsule was the first form of pirfenidone, and its low unit strength allows a gradual start. Film-coated tablets of 267 mg and 801 mg also exist; the 801 mg tablet replaces three capsules at full dose.
Pirfenidone is used for idiopathic pulmonary fibrosis in adults, where it slows the decline in lung function. Treatment starts at one capsule three times a day and rises over two weeks to three capsules three times a day, 2,403 mg daily, taken with food to limit nausea and dizziness. Photosensitivity and rash are common, so patients avoid strong sun and use high-factor sunscreen. Liver tests are checked before and during treatment. Fluvoxamine is contraindicated, and smoking speeds metabolism and reduces exposure.
Sourcing notes. Pirfenidone is a prescription-only specialist medicine, dispensed mainly through respiratory clinics and hospital pharmacies. Capsules come in bottles or blisters, and packs are often sized separately for titration and maintenance, so state which you need. Ask for a CTD or ACTD dossier, bioequivalence data against the reference capsule and zone IVb stability data for tropical markets. Storage follows the labelled room-temperature condition. Each batch should come with a CoA, plus the GMP certificate and a CoPP. In your enquiry, state pack format, shelf life at delivery and target country.
Pirfenidone Capsule — third party manufacturing & bulk supply
Pirfenidone Capsule 267 mg is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:
Indicative minimum order quantity
Pirfenidone Capsule is supplied as Capsules — an oral solid dosage form, so the indicative MOQ is 200,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.
Manufacturers of Pirfenidone Capsule listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.
Request a quote for Pirfenidone Capsule →Usually answered within 48 hours, with matched manufacturers, indicative prices and document status.
Frequently Asked Questions
Pirfenidone is used to treat idiopathic pulmonary fibrosis (IPF), a chronic and progressive lung disease. It helps slow the decline in lung function by reducing fibrosis and inflammation in lung tissue.
Pirfenidone is a small-molecule antifibrotic and anti-inflammatory agent. Its chemical name is 5-methyl-1-phenyl-2-(1H)-pyridone.
Pirfenidone is marketed under the trade name Esbriet in the USA, EU, and UK. Generic pirfenidone is also available in several EU countries under different brand names.
Pirfenidone was originally developed and is marketed by Roche under the brand name Esbriet. Generic versions are manufactured by multiple pharmaceutical companies.
The generic name is Pirfenidone.
The brand name is Esbriet. Generic brands are also available depending on the region.
Pirfenidone is manufactured in various countries including the USA and EU member states by Roche and approved generic manufacturers.
Related Products
Acetylcysteine 200mg/ml
Strength:
200 mg/mL
Form: Injection
Reference Brands: Acetadote(USA), Parvolex (EU)
View DetailsPhospholipid Fraction FROM Bovine LUNG (Surfactant)
Strength:
50 mg
Form: For intratracheal administration
Reference Brands:
View DetailsGlycopyrrolate,Indacaterol
Strength:
110/50 MCG
Form: Inhaler
Reference Brands: Ultibro Breezhaler (EU)
View DetailsBeractant
Strength:
25 mg/mL
Form: Intratracheal suspension
Reference Brands: Survanta(US & EU)
View DetailsAcetylcysteine Oral Solution
Strength:
10% (100 mg/mL), 20% (200 mg/mL)
Form: Oral Solution
Reference Brands: Mucomyst(US); Fluimucil(EU)
View DetailsPoractant Alfa
Strength:
80 mg/mL (120 mg/1.5 mL, 240 mg/3 mL vials)
Form: Intratracheal suspension
Reference Brands: Curosurf(Eu & US)
View DetailsUsually answered within 48 hours | GMP documents shared before you commit